Indolium 1 Exerts Activity against Vemurafenib-Resistant Melanoma In Vivo
The development of targeted therapies (BRAF/MEK inhibitors) and immunotherapy have had a major impact on the treatment of melanoma.However, the majority of patients with advanced melanomas succumb to their disease.The mechanisms of resistance to both targeted therapies and immunotherapies are emtek freestone finger pull numerous and have been well-